These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30079558)

  • 21. SUFU mediates EMT and Wnt/β-catenin signaling pathway activation promoted by miRNA-324-5p in human gastric cancer.
    Peng Y; Zhang X; Lin H; Deng S; Qin Y; Yuan Y; Feng X; Wang J; Chen W; Hu F; Yan R; Zhao Y; Cheng Y; Wei Y; Fan X; Ashktorab H; Smoot D; Li S; Meltzer SJ; Jin Z
    Cell Cycle; 2020 Oct; 19(20):2720-2733. PubMed ID: 33017570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KLF3 Transcription Activates WNT1 and Promotes the Growth and Metastasis of Gastric Cancer via Activation of the WNT/β-Catenin Signaling Pathway.
    Li Y; Wang Y; Zou Q; Li S; Zhang F
    Lab Invest; 2023 Jun; 103(6):100078. PubMed ID: 36827869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer.
    Peng Q; Chen L; Wu W; Wang J; Zheng X; Chen Z; Jiang Q; Han J; Wei L; Wang L; Huang J; Ma J
    Cell Death Dis; 2018 Nov; 9(12):1146. PubMed ID: 30451837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
    Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DEK promotes the proliferation and invasion of lung cancers and indicates poor prognosis in lung adenocarcinomas.
    Yang MQ; Bai LL; Lei L; Zheng YW; Wang Z; Li ZH; Liu CC; Huang WJ; Xu HT
    Oncol Rep; 2020 Apr; 43(4):1338-1348. PubMed ID: 32020224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RSPO2 enhances cell invasion and migration via the WNT/β-catenin pathway in human gastric cancer.
    Zhang H; Han X; Wei B; Fang J; Hou X; Lan T; Wei H
    J Cell Biochem; 2019 Apr; 120(4):5813-5824. PubMed ID: 30362605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway.
    Ye J; Xu J; Li Y; Huang Q; Huang J; Wang J; Zhong W; Lin X; Chen W; Lin X
    Mol Oncol; 2017 Sep; 11(9):1208-1224. PubMed ID: 28580735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/β-catenin pathway and indicates a poor prognosis.
    Liu WG; Xu Q
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7905-7912. PubMed ID: 31599413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/β-catenin signaling pathway in breast cancer.
    Li K; Pan W; Ma Y; Xu X; Gao Y; He Y; Wei L; Zhang J
    Pathol Res Pract; 2019 Oct; 215(10):152573. PubMed ID: 31399258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.
    Gu X; Wang Y; Wang H; Ni Q; Zhang C; Zhu J; Huang W; Xu P; Mao G; Yang S
    Med Oncol; 2015 Jul; 32(7):195. PubMed ID: 26033031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
    Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
    Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. lncRNA VIM‑AS1 promotes cell proliferation, metastasis and epithelial‑mesenchymal transition by activating the Wnt/β‑catenin pathway in gastric cancer.
    Sun JG; Li XB; Yin RH; Li XF
    Mol Med Rep; 2020 Dec; 22(6):4567-4578. PubMed ID: 33173977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression.
    Yu S; Li L; Cai H; He B; Gao Y; Li Y
    J Exp Clin Cancer Res; 2021 Feb; 40(1):54. PubMed ID: 33526068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RHBDD1 Promotes the Growth and Stemness Characteristics of Gastric Cancer Cells by Activating Wnt/β-catenin Signaling Pathway.
    Yang Y; Yuan Y; Xia B
    Curr Stem Cell Res Ther; 2024; 19(7):1021-1028. PubMed ID: 37861049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma.
    Zhou Y; Lan J; Wang W; Shi Q; Lan Y; Cheng Z; Guan H
    J Mol Histol; 2013 Oct; 44(5):555-63. PubMed ID: 23504200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-375-3p/YWHAZ/β-catenin axis regulates migration, invasion, EMT in gastric cancer cells.
    Guo F; Gao Y; Sui G; Jiao D; Sun L; Fu Q; Jin C
    Clin Exp Pharmacol Physiol; 2019 Feb; 46(2):144-152. PubMed ID: 30353914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SPAG5 contributes to the progression of gastric cancer by upregulation of Survivin depend on activating the wnt/β-catenin pathway.
    Liu G; Liu S; Cao G; Luo W; Li P; Wang S; Chen Y
    Exp Cell Res; 2019 Jun; 379(1):83-91. PubMed ID: 30904482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-Regulated Mechanism of EZH2 and KDM6A on SALL4 Modulates Tumor Progression via Wnt/β-Catenin Pathway in Gastric Cancer.
    Ren L; Deng H; Jiang Y; Liu C
    Dig Dis Sci; 2023 Apr; 68(4):1292-1305. PubMed ID: 36877334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRIM52 regulates the proliferation and invasiveness of lung cancer cells via the Wnt/β‑catenin pathway.
    Mu X; Li H; Zhou L; Xu W
    Oncol Rep; 2019 Jun; 41(6):3325-3334. PubMed ID: 31002351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.